Literature DB >> 28351583

Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer.

D Borchiellini1, M C Etienne-Grimaldi2, R J Bensadoun3, K Benezery4, O Dassonville5, G Poissonnet5, L Llorca2, N Ebran2, P Formento2, Y Château6, J Thariat4, G Milano2.   

Abstract

INTRODUCTION: Single nucleotide polymorphisms (SNPs) of DNA repair and apoptosis genes have been associated with outcome in head and neck squamous cell carcinoma (HNSCC) patients receiving radiotherapy (RT). Our goal was to conduct a candidate gene study in HNSCC patients receiving RT or chemoRT.
METHODS: 122 non-resectable HNSCC patients undergoing RT (N=38) or chemoRT (N=84) between 1992 and 2006 were retrospectively analyzed. ERCC1 Lys259Thr (rs735482), ERCC2 Lys751Gln (rs13181), ERCC5 His46His C>T (rs1047768), XRCC1 Arg399Gln (rs25487), TP53 Arg72Pro (rs1042522) and MDM2 309T>G (rs2279744) were analyzed on tumor DNA. SNP profile was considered to assess RT-related toxicity.
RESULTS: All 120 evaluable patients experienced RT-related toxicity at any time. Among them, 83% had G3-4 acute side-effects during RT, mainly dysphagia, mucositis, epithelitis and/or xerostomia (DMEX). 28/105 patients (27%) had early G3-4 toxicity up to 3months after the end of RT. 29/96 patients (30%) had G3-4 late toxicity thereafter. The presence of G allele of MDM2 or Thr allele of ERCC1 was associated with a significantly higher risk of acute and/or early DMEX toxicity. The MDM2 309GG genotype was linked to a higher risk of acute G3-4 dermatitis. The ERCC5 TT genotype was associated with more frequent G3-4 late cervical skin fibrosis or xerostomia. Pro allele of TP53 72 was associated with a higher risk of G3-4 osteoradionecrosis.
CONCLUSION: Relevant SNPs in DNA repair (ERCC1 and ERCC5) and apoptosis (MDM2 and TP53) genes might influence the severity of radiation-related side-effects in HNSCC patients. Prospective clinical SNP-based validation studies are needed on these bases.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28351583     DOI: 10.1016/j.oraloncology.2017.02.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  7 in total

1.  The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma.

Authors:  Yu-Liang Huang; Jun-Rong Wu; Min Fang; Hui-Liu Zhao; Zhi-Min Liu; Jian Ye; Ling-Sha Huang; Bo Zhu
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

2.  CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes.

Authors:  Nuzhat Sial; Mukhtiar Ahmad; Muhammad Safdar Hussain; Muhammad Junaid Iqbal; Yasir Hameed; Mehran Khan; Mustansar Abbas; Rizwan Asif; Jalil Ur Rehman; Muhammad Atif; Muhammad Rashid Khan; Zahid Hameed; Hina Saeed; Rida Tanveer; Saba Saeed; Aneeqa Sharif; Hafiz Muhammad Asif
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

Review 3.  Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury.

Authors:  Zengfu Zhang; Jialin Zhou; Vivek Verma; Xu Liu; Meng Wu; Jinming Yu; Dawei Chen
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

4.  The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma.

Authors:  Ruijie Ming; Enhao Wang; Jiahui Wei; Jinxiong Shen; Shimin Zong; Hongjun Xiao
Journal:  Front Oncol       Date:  2021-07-30       Impact factor: 6.244

5.  Association between NF-κB Activation in Peripheral Blood Mononuclear Cells and Late Skin and Subcutaneous Fibrosis following Radiotherapy.

Authors:  Yapin Su; Yuyu Zhang; Meiting Sun; Wenhui Liu; Fengli Pei; Fujun Han
Journal:  Biomed Res Int       Date:  2020-07-21       Impact factor: 3.411

6.  The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese.

Authors:  Xueling Lan; Ying Li; Yefeng Wu; Xia Li; Lan Xu
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

Review 7.  Low dose ionizing radiation effects on the immune system.

Authors:  Katalin Lumniczky; Nathalie Impens; Gemma Armengol; Serge Candéias; Alexandros G Georgakilas; Sabine Hornhardt; Olga A Martin; Franz Rödel; Dörthe Schaue
Journal:  Environ Int       Date:  2020-12-05       Impact factor: 9.621

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.